Schedule 13G ownership disclosure
Avalo Therapeutics, Inc.
Security class unavailable · CUSIP: 05338F306
Event date: 2024-05-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001013594-24-000465
- Form type
- SC 13G
- Filer
- Allostery Investments LP
- CIK
- CIK 1978599
- Filed
- May 13, 2024
- Reporting period
- May 01, 2024
- Description
- Schedule 13G beneficial ownership